Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by TNFRSF17 is a member of the TNF-receptor superfamily. Additionally we are shipping TNFRSF17 Proteins (50) and TNFRSF17 Kits (20) and many more products for this protein.
Showing 10 out of 133 products:
Mouse (Murine) Monoclonal TNFRSF17 Primary Antibody for FACS - ABIN4895658
Notley, Baker, Ehrenstein: Secreted IgM enhances B cell receptor signaling and promotes splenic but impairs peritoneal B cell survival. in Journal of immunology (Baltimore, Md. : 1950) 2010
Show all 5 Pubmed References
Human Polyclonal TNFRSF17 Primary Antibody for ELISA (Detection), FACS - ABIN4899163
Moir, Malaspina, Pickeral, Donoghue, Vasquez, Miller, Krishnan, Planta, Turney, Justement, Kottilil, Dybul, Mican, Kovacs, Chun, Birse, Fauci: Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. in The Journal of experimental medicine 2004
Show all 5 Pubmed References
Human Monoclonal TNFRSF17 Primary Antibody for BP, ELISA - ABIN4283793
Sakurai, Hase, Kanno, Kojima, Okumura, Kobata: TACI regulates IgA production by APRIL in collaboration with HSPG. in Blood 2007
Show all 3 Pubmed References
Human Polyclonal TNFRSF17 Primary Antibody for FACS - ABIN4895686
Frigyesi, Adolfsson, Ali, Christophersen, Johnsson, Turesson, Gullberg, Hansson, Nilsson: Robust isolation of malignant plasma cells in multiple myeloma. in Blood 2014
Show all 2 Pubmed References
Human Monoclonal TNFRSF17 Primary Antibody for FACS - ABIN4255822
Lyu, Rai, Ahn, Sung, Cheung, Marks, Aggarwal, Aguiar, Gandhi, Rosenblum: The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo. in Neoplasia (New York, N.Y.) 2010
Show all 2 Pubmed References
Human Polyclonal TNFRSF17 Primary Antibody for FACS - ABIN4895684
Bloom, Chang, Pauly, Kwun, Fechner, Hayes, Samaniego, Knechtle: BAFF is increased in renal transplant patients following treatment with alemtuzumab. in American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009
Mouse (Murine) Monoclonal TNFRSF17 Primary Antibody for BP, FACS - ABIN4283791
Hardenberg, Fernandez, Hendriks, Chebli, Jacquet, Sitbon, Hahne, Medema: APRIL facilitates viral-induced erythroleukemia but is dispensable for T cell immunity and lymphomagenesis. in Journal of leukocyte biology 2008
Studied expression of B-cell maturation antigen (BCMA) in osteoblasts and the toxic effect of chromium on its expression; found BCMA is involved in osteogenesis of osteoblasts; chromium downregulates expression of BCMA in osteoblasts.
BCMA has other contributors for ligands binding except DxL motif. The affinity of BCMA for APRIL higher than for BAFF (show TNFSF13B Antibodies) may be caused by the segment outside of the conservative DxL motif. Moreover, the exposition of new binding modes of BCMA2 interacting with APRIL may establish the foundation of designing novel drugs in the future
New molecular mechanisms of in vivo Multiple Myeloma (MM) growth and immunosuppression critically dependent on BCMA and APRIL in the Bone marrow microenvironment, further supporting targeting this prominent pathway in MM.
We have identified a specific serum protein, BCMA, as a novel independent marker for both monitoring and predicting outcomes for MM patients. We have shown that sBCMA is elevated in MM patients, and can be used to follow their disease status, PFS and OS.
The expression levels of serum BAFF (show TNFSF13B Antibodies) and the three receptors (TACI (show TNFRSF13B Antibodies), BCMA and BAFF-R (show TNFRSF13C Antibodies)) in non-Hodgkin lymphoma patients were significantly higher than in healthy controls.
Decreased BCMA expression on peripheral B cells according to severe disease activity suggests that BCMA plays an important regulating role in B-cell hyperactivity and immune tolerance homeostasis in systemic lupus erythematosus patients
results suggest that Akt (show AKT1 Antibodies) and JNK (show MAPK8 Antibodies) pathways are involved in the regulation of B-cell maturation antigen (BCMA)
shedding of BCMA by gamma-secretase controls plasma cells in the bone marrow and yields a potential biomarker for B-cell involvement in human autoimmune diseases
Data show significant differences in expression of tumour necrosis factor (show TNF Antibodies) family (BAFF (show TNFSF13B Antibodies)) receptors BAFF-R (show TNFRSF13C Antibodies), BCMA and TACI (show TNFRSF13B Antibodies) in patients with and without anti-Jo-1 or anti-Ro52 (show TRIM21 Antibodies)/anti-Ro60 (show TROVE2 Antibodies) autoantibodies.
High BCMA expression is associated with breast cancer.
high affinity antibody blocks the binding of the native ligands APRIL and BAFF (show TNFSF13B Antibodies) to BCMA. This finding is rationalized by the high resolution crystal structure of the Fab (show FANCB Antibodies) fragment in complex with the extracellular domain of BCMA
Elimination of B lymphocyte stimulator (show TNFSF13B Antibodies) receptor 3 (BR-3) and BCMA inhibits the development of SLE in NZM mice.
we have identified a novel role for BCMA to control excess BAFF (show TNFSF13B Antibodies) production in murine lupus through restraining the accumulation of BAFF (show TNFSF13B Antibodies)-producing neutrophils.
Heteromers consisting of one BAFF (show TNFSF13B Antibodies) and two APRIL bind to receptor TACI (show TNFRSF13B Antibodies), BCMA but not to BAFFR (show TNFRSF13C Antibodies).
BCMA is dispensable for the development of SLE in NZM mice. BAFF (show TNFSF13B Antibodies)-BCMA interactions contribute to SLE.
Study reveals that BCMA works to control B cell homeostasis and self-tolerance in systemic autoimmunity.
Blimp-1 (show PRDM1 Antibodies) is a positive regulator of the expression of BCMA gene in mouse plasma cells.
The 5'-flanking sequence from -820 to +145 bp of BCMA is of promoter activity.
A vital role of BCMA in bone marrow plasma cell survival.
B cell maturation antigen, the receptor for a proliferation-inducing ligand (show TNFSF13 Antibodies) and B cell-activating factor (show TNFSF13B Antibodies) of the TNF (show TNF Antibodies) family, induces antigen presentation in B cells.
The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is preferentially expressed in mature B lymphocytes, and may be important for B cell development and autoimmune response. This receptor has been shown to specifically bind to the tumor necrosis factor (ligand) superfamily, member 13b (TNFSF13B/TALL-1/BAFF), and to lead to NF-kappaB and MAPK8/JNK activation. This receptor also binds to various TRAF family members, and thus may transduce signals for cell survival and proliferation.
tumor necrosis factor receptor superfamily member 17
, tumor necrosis factor receptor superfamily, member 17
, B cell maturation antigen
, B-cell maturation factor
, B-cell maturation protein